Viri Sode
- Product NDC
- 83027-0070
- 11-digit product format
- 830270070
- Labeler code
- 83027
- Product ID
- 83027-0070_abb0cbbe-e25f-453e-892e-8b51f6832406
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Cytomegalovirus Nosode, Herpes Simplex I Nosode, Herpes Simplex II Nosode, Influenzinum, Rubella Nosode, Hepatitis A Nosode, Hepatitis B Nosode, Hepatitis C Nosode, Epstein Barr Virus Nosode, Herpes Zoster Nosode
- Dosage form
- SPRAY
- Route
- ORAL
- Labeler
- Nutritional Specialties, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2023-05-30
- Marketing end
- 2028-12-19
- Substance
- HEPATITIS A VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 3; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); RUBELLA VIRUS
- Active strength
- 30; 30; 30; 16; 16; 15; 15; 16; 16; 16; 16; 16; 16 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
- NDC exclude flag
- No
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Viri Sode
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| HEPATITIS A VIRUS | 30 [hp_X]/mL |
| HEPATITIS B VIRUS | 30 [hp_X]/mL |
| HEPATITIS C VIRUS | 30 [hp_X]/mL |
| HUMAN HERPESVIRUS 1 | 16 [hp_X]/mL |
| HUMAN HERPESVIRUS 2 | 16 [hp_X]/mL |
| HUMAN HERPESVIRUS 3 | 15 [hp_C]/mL |
| HUMAN HERPESVIRUS 4 | 15 [hp_C]/mL |
| HUMAN HERPESVIRUS 5 | 16 [hp_X]/mL |
| INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) | 16 [hp_X]/mL |
| INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) | 16 [hp_X]/mL |
| INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) | 16 [hp_X]/mL |
| INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) | 16 [hp_X]/mL |
| RUBELLA VIRUS | 16 [hp_X]/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | G54MT8V18G, 77H9EM77P7, QI56415283, 22G38P19RL, 74J6DNH49U, 9885M7D6JP, 2A26YW7PNX, 7COI029E6K, P483J7GX6D, 34C49NV47P, TBV2PPG6EF, H2198F8ZNA, U751HEX436 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 83027-0070-1 | Viri Sode | 60 mL in 1 BOTTLE, SPRAY | SPRAY | 60 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 83027-0070 | VIRI SODE (CYTOMEGALOVIRUS NOSODE, HERPES SIMPLEX I NOSODE, HERPES SIMPLEX II NOSODE, INFLUENZINUM, RUBELLA NOSODE, HEPATITIS A NOSODE, HEPATITIS B NOSODE, HEPATITIS C NOSODE, EPSTEIN BARR VIRUS NOSODE, HERPES ZOSTER NOSODE) SPRAY [NUTRITIONAL SPECIALTIES, INC.] | 2 | Current NDC, 1 package rows | 20250516_96512394-a9d8-488d-ba88-b15d3d988f61.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 83027-0070-1 | 83027007001 | 60 mL in 1 BOTTLE, SPRAY (83027-0070-1) | 60 ml | 2023-05-30 | 2028-12-19 | No | No | Historical |